{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:58:30Z","timestamp":1790459910131,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973341"],"award-info":[{"award-number":["81973341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900825"],"award-info":[{"award-number":["31900825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04243"],"award-info":[{"award-number":["17H04243"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mounting evidence suggests the key role of brain-derived neurotrophic factor (BDNF) in the dopaminergic neurotoxicity of Parkinson\u2019s disease (PD). Activation of NF-E2-related factor-2 (Nrf2) and inhibition of methyl CpG-binding protein 2 (MeCP2) can regulate BDNF upregulation. However, the regulation of BDNF by Nrf2 and MeCP2 in the PD pathogenesis has not been reported. Here, we revealed that Nrf2\/MeCP2 coordinately regulated BDNF transcription, reversing the decreased levels of BDNF expression in 1-methyl-4-phenylpyridinium (MPP<jats:sup>+<\/jats:sup>)-treated SH-SY5Y cells and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Repeated administration of sulforaphane (SFN, an Nrf2 activator) attenuated dopaminergic neurotoxicity in MPTP-treated mice through activation of BDNF and suppression of MeCP2 expression. Furthermore, intracerebroventricular injection of MeCP2-HDO, a DNA\/RNA heteroduplex oligonucleotide (HDO) silencing MeCP2 expression, ameliorated dopaminergic neurotoxicity in MPTP-treated mice via activation of Nrf2 and BDNF expression. Moreover, we found decreased levels of Nrf2 and BDNF, and increased levels of MeCP2 protein expression in the striatum of patients with dementia with Lewy bodies (DLB). Interesting, there were correlations between BDNF and Nrf2 (or MeCP2) expression in the striatum from DLB patients. Therefore, it is likely that the activation of BDNF transcription by activation of Nrf2 and\/or suppression of MeCP2 could be a new therapeutic approach for PD.<\/jats:p>","DOI":"10.1038\/s41420-022-01063-9","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T06:07:01Z","timestamp":1653026821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity"],"prefix":"10.1038","volume":"8","author":[{"given":"Qianqian","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanbu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-0713","authenticated-orcid":false,"given":"Qi","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0489-9239","authenticated-orcid":false,"given":"Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-6867","authenticated-orcid":false,"given":"Ji-chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1073\/pnas.1618627114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, He L, Iuvone PM, et al. Alpha-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation. Proc Natl Acad Sci USA. 2017;114:1183\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257\u201372.","journal-title":"Lancet Neurol"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, et al. TrkB neurotrophic activities are blocked by alpha-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2017;114:10773\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1063_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang EJ, Reichardt LF. Trk receptors: Roles in neuronal signal transduction. Annu Rev Biochem. 2003;72:609\u201342.","journal-title":"Annu Rev Biochem"},{"key":"1063_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.phrs.2015.12.019","volume":"105","author":"T Mizui","year":"2016","unstructured":"Mizui T, Ishikawa Y, Kumanogoh H, Kojima M. Neurobiological actions by three distinct subtypes of brain-derived neurotrophic factor: Multi-ligand model of growth factor signaling. Pharm Res. 2016;105:93\u201398.","journal-title":"Pharm Res"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1523\/JNEUROSCI.5123-04.2005","volume":"25","author":"HK Teng","year":"2005","unstructured":"Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD, et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci. 2005;25:5455\u201363.","journal-title":"J Neurosci"},{"key":"1063_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cne.903420302","volume":"342","author":"KB Seroogy","year":"1994","unstructured":"Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J Comp Neurol. 1994;342:321\u201334.","journal-title":"J Comp Neurol"},{"key":"1063_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fncel.2014.00254","volume":"8","author":"M Baydyuk","year":"2014","unstructured":"Baydyuk M, Xu B. BDNF signaling and survival of striatal neurons. Front Cell Neurosci. 2014;8:254.","journal-title":"Front Cell Neurosci"},{"key":"1063_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, et al. Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol. 2000;166:127\u201335.","journal-title":"Exp Neurol"},{"key":"1063_CR10","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.5114\/aoms.2015.56342","volume":"11","author":"S Bathina","year":"2015","unstructured":"Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015;11:1164\u201378.","journal-title":"Arch Med Sci"},{"key":"1063_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/187152708783885200","volume":"7","author":"F Molina-Holgado","year":"2008","unstructured":"Molina-Holgado F, Doherty P, Williams G. Tandem repeat peptide strategy for the design of neurotrophic factor mimetics. CNS Neurol Disord Drug Targets. 2008;7:110\u20139.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1063_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2005.05.072","volume":"1052","author":"M Sun","year":"2005","unstructured":"Sun M, Kong LX, Wang XD, Lu XG, Gao QS, Geller AI. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson\u2019s disease. Brain Res. 2005;1052:119\u201329.","journal-title":"Brain Res"},{"key":"1063_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0006-8993(99)02116-2","volume":"847","author":"RL Klein","year":"1999","unstructured":"Klein RL, Lewis MH, Muzyczka N, Meyer EM. Prevention of 6-hydroxydopamine-induced rotational behavior by BDNF somatic gene transfer. Brain Res. 1999;847:314\u201320.","journal-title":"Brain Res"},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00406-017-0848-0","volume":"268","author":"JC Zhang","year":"2018","unstructured":"Zhang JC, Yao W, Dong C, Han M, Shirayama Y, Hashimoto K. Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress. Eur Arch Psychiatry Clin Neurosci. 2018;268:865\u201370.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1063_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jnutbio.2016.10.004","volume":"39","author":"JC Zhang","year":"2017","unstructured":"Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, et al. Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation. J nutritional Biochem. 2017;39:134\u201344.","journal-title":"J nutritional Biochem"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharm Sci. 2013;34:340\u20136.","journal-title":"Trends Pharm Sci"},{"key":"1063_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med. 2015;88:93\u2013100. Pt B","journal-title":"Free Radic Biol Med"},{"key":"1063_CR18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/mp.2016.144","volume":"22","author":"E Bouvier","year":"2017","unstructured":"Bouvier E, Brouillard F, Molet J, Claverie D, Cabungcal JH, Cresto N, et al. Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression. Mol Psychiatry. 2017;22:1701\u201313.","journal-title":"Mol Psychiatry"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3389\/fphar.2018.01182","volume":"9","author":"K Hashimoto","year":"2018","unstructured":"Hashimoto K. Essential role of Keap1-Nrf2 signaling in mood disorders: overview and future perspective. Front Pharm. 2018;9:1182.","journal-title":"Front Pharm"},{"key":"1063_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.9758\/cpn.2012.10.2.94","volume":"10","author":"Y Shirai","year":"2012","unstructured":"Shirai Y, Fujita Y, Hashimoto K. Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration. Clin Psychopharmacol Neurosci. 2012;10:94\u201398.","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"1063_CR21","doi-asserted-by":"publisher","first-page":"e0127244","DOI":"10.1371\/journal.pone.0127244","volume":"10","author":"Y Shirai","year":"2015","unstructured":"Shirai Y, Fujita Y, Hashimoto R, Ohi K, Yamamori H, Yasuda Y, et al. Dietary intake of sulforaphane-rich broccoli sprout extracts during juvenile and adolescence can prevent phencyclidine-induced cognitive deficits at adulthood. PLoS ONE. 2015;10:e0127244.","journal-title":"PLoS ONE"},{"key":"1063_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep30659","volume":"6","author":"W Yao","year":"2016","unstructured":"Yao W, Zhang JC, Ishima T, Dong C, Yang C, Ren Q, et al. Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice. Sci Rep. 2016;6:30659.","journal-title":"Sci Rep."},{"key":"1063_CR23","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1126\/science.1090842","volume":"302","author":"K Martinowich","year":"2003","unstructured":"Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, et al. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science. 2003;302:890\u20133.","journal-title":"Science"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"12547","DOI":"10.1523\/JNEUROSCI.0324-14.2014","volume":"34","author":"D Bambah-Mukku","year":"2014","unstructured":"Bambah-Mukku D, Travaglia A, Chen DY, Pollonini G, Alberini CM. A positive autoregulatory BDNF feedback loop via C\/EBP\u03b2 mediates hippocampal memory consolidation. J Neurosci. 2014;34:12547\u201359.","journal-title":"J Neurosci"},{"key":"1063_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01261-6","volume":"11","author":"W Yao","year":"2021","unstructured":"Yao W, Lin S, Su J, Cao Q, Chen Y, Chen J, et al. Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents. Transl Psychiatry. 2021;11:140.","journal-title":"Transl Psychiatry"},{"key":"1063_CR26","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/ars.2010.3731","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J, Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Sign. 2011;14:2347\u201360.","journal-title":"Antioxid Redox Sign"},{"key":"1063_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422\u201337.","journal-title":"Neuron"},{"key":"1063_CR28","first-page":"1948","volume":"8","author":"T Xie","year":"2013","unstructured":"Xie T, Zhang J, Yuan X, Yang J, Ding W, Huang X, et al. Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson\u2019s disease. Neural Regen Res. 2013;8:1948\u201357.","journal-title":"Neural Regen Res"},{"key":"1063_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8969","volume":"6","author":"K Nishina","year":"2015","unstructured":"Nishina K, Piao W, Yoshida-Tanaka K, Sujino Y, Nishina T, Yamamoto T, et al. DNA\/RNA heteroduplex oligonucleotide for highly efficient gene silencing. Nat Commun. 2015;6:7969.","journal-title":"Nat Commun"},{"key":"1063_CR30","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1093\/nar\/gkz492","volume":"47","author":"K Yoshioka","year":"2019","unstructured":"Yoshioka K, Kunieda T, Asami Y, Guo H, Miyata H, Yoshida-Tanaka K, et al. Highly efficient silencing of microRNA by heteroduplex oligonucleotides. Nucleic Acids Res. 2019;47:7321\u201332.","journal-title":"Nucleic Acids Res"},{"key":"1063_CR31","doi-asserted-by":"publisher","first-page":"1600194","DOI":"10.1002\/mnfr.201600194","volume":"61","author":"J Kim","year":"2017","unstructured":"Kim J, Lee S, Choi BR, Yang H, Hwang Y, Park JH, et al. Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways. Mol Nutr Food Res. 2017;61:1600194.","journal-title":"Mol Nutr Food Res"},{"key":"1063_CR32","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1093\/nar\/gks409","volume":"40","author":"BN Chorley","year":"2012","unstructured":"Chorley BN, Campbell MR, Wang X, Karaca M, Sambandan D, Bangura F, et al. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 2012;40:7416\u201329.","journal-title":"Nucleic Acids Res"},{"key":"1063_CR33","doi-asserted-by":"publisher","first-page":"e98878","DOI":"10.15252\/embj.201798878","volume":"37","author":"SS Kang","year":"2018","unstructured":"Kang SS, Ahn EH, Zhang ZT, Liu X, Manfredsson FP, Sandoval IM, et al. alpha-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson\u2019s disease. Embo J. 2018;37:e98878.","journal-title":"Embo J"},{"key":"1063_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1545-x","volume":"16","author":"AB DePaula-Silva","year":"2019","unstructured":"DePaula-Silva AB, Gorbea C, Doty DJ, Libbey JE, Sanchez JMS, Hanak TJ, et al. Differential transcriptional profiles identify microglial- and macrophage-specific gene markers expressed during virus-induced neuroinflammation. J Neuroinflammation. 2019;16:152.","journal-title":"J Neuroinflammation"},{"key":"1063_CR35","doi-asserted-by":"publisher","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","volume":"26","author":"S Brahmachari","year":"2006","unstructured":"Brahmachari S, Fung YK, Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci. 2006;26:4930\u20139.","journal-title":"J Neurosci"},{"key":"1063_CR36","first-page":"E5815","volume":"115","author":"Q Ren","year":"2018","unstructured":"Ren Q, Ma M, Yang J, Nonaka R, Yamaguchi A, Ishikawa KI, et al. Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease. Proc Natl Acad Sci USA. 2018;115:E5815\u2013E5823.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1063_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.tpj.6500360","volume":"6","author":"F Fumagalli","year":"2006","unstructured":"Fumagalli F, Racagni G, Riva MA. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson\u2019s disease. Pharmacogenomics J. 2006;6:95\u2013104.","journal-title":"Pharmacogenomics J"},{"key":"1063_CR38","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.neuroscience.2014.12.080","volume":"290","author":"MD Sconce","year":"2015","unstructured":"Sconce MD, Churchill MJ, Moore C, Meshul CK. Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson\u2019s disease. Neuroscience. 2015;290:454\u201371.","journal-title":"Neuroscience"},{"key":"1063_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep34339","volume":"6","author":"J He","year":"2016","unstructured":"He J, Xiang Z, Zhu X, Ai Z, Shen J, Huang T, et al. Neuroprotective effects of 7, 8-dihydroxyflavone on midbrain dopaminergic neurons in MPP(+)-treated monkeys. Sci Rep. 2016;6:34339.","journal-title":"Sci Rep."},{"key":"1063_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","volume":"237","author":"A Fujita","year":"2020","unstructured":"Fujita A, Fujita Y, Pu Y, Chang L, Hashimoto K. MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling. Psychopharmacology. 2020;237:83\u201392.","journal-title":"Psychopharmacology"},{"key":"1063_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","volume":"26","author":"A Kobayashi","year":"2006","unstructured":"Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol. 2006;26:221\u20139.","journal-title":"Mol Cell Biol"},{"key":"1063_CR42","doi-asserted-by":"publisher","first-page":"529219","DOI":"10.1155\/2013\/529219","volume":"2013","author":"E Kobayashi","year":"2013","unstructured":"Kobayashi E, Suzuki T, Yamamoto M. Roles nrf2 plays in myeloid cells and related disorders. Oxid Med Cell Longev. 2013;2013:529219.","journal-title":"Oxid Med Cell Longev"},{"key":"1063_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharm Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"1063_CR44","doi-asserted-by":"publisher","first-page":"648788","DOI":"10.3389\/fnut.2021.648788","volume":"8","author":"JW Fahey","year":"2021","unstructured":"Fahey JW, Kensler TW. The challenges of designing and implementing clinical trials with broccoli sprouts\u2026 and turning evidence into public health action. Front Nutr. 2021;8:648788.","journal-title":"Front Nutr"},{"key":"1063_CR45","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/ars.2010.3731","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J, Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal. 2011;14:2347\u201360.","journal-title":"Antioxid Redox Signal"},{"key":"1063_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/npr2.12060","volume":"39","author":"Y Pu","year":"2019","unstructured":"Pu Y, Qu Y, Chang L, Wang SM, Zhang K, Ushida Y, et al. Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP. Neuropsychopharmacol Rep. 2019;39:247\u201351.","journal-title":"Neuropsychopharmacol Rep."},{"key":"1063_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuron.2006.09.037","volume":"52","author":"Z Zhou","year":"2006","unstructured":"Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron. 2006;52:255\u201369.","journal-title":"Neuron"},{"key":"1063_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","volume":"49","author":"QA Chang","year":"2006","unstructured":"Chang QA, Khare G, Dani V, Nelson S, Jaenisch R. The disease progression mutant mice is affected of Mecp2 by the level of BDNF expression. Neuron. 2006;49:341\u20138.","journal-title":"Neuron"},{"key":"1063_CR49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/nn.2615","volume":"13","author":"HI Im","year":"2010","unstructured":"Im HI, Hollander JA, Bali P, Kenny PJ. MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 2010;13:1120\u2013U1121.","journal-title":"Nat Neurosci"},{"key":"1063_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-020-09332-3","volume":"12","author":"HM Lee","year":"2020","unstructured":"Lee HM, Kuijer MB, Ruiz Blanes N, Clark EP, Aita M, Galiano Arjona L, et al. A small-molecule screen reveals novel modulators of MeCP2 and X-chromosome inactivation maintenance. J Neurodev Disord. 2020;12:29.","journal-title":"J Neurodev Disord"},{"key":"1063_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41401-021-00727-z","volume":"43","author":"R Tang","year":"2021","unstructured":"Tang R, Cao QQ, Hu SW, He LJ, Du PF, Chen G, et al. Sulforaphane activates anti-inflammatory microglia, modulating stress resilience associated with BDNF transcription. Acta Pharm Sin. 2021;43:829\u201339.","journal-title":"Acta Pharm Sin"},{"key":"1063_CR52","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature16159","volume":"528","author":"Y Sztainberg","year":"2015","unstructured":"Sztainberg Y, Chen HM, Swann JW, Hao S, Tang B, Wu Z, et al. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature. 2015;528:123\u20136.","journal-title":"Nature"},{"key":"1063_CR53","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","volume":"62","author":"Y Saito","year":"2003","unstructured":"Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol. 2003;62:644\u201354.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01063-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:33:12Z","timestamp":1669303992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-01063-9","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}